Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

The rapid development of drug-resistance by Trypanosoma evansi in immunosuppressed mice.

Osman AS, Jennings FW, Holmes PH.

Acta Trop. 1992 Feb;50(3):249-57.

PMID:
1348601
2.

Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya.

Otsyula M, Kamar K, Mutugi M, Njogu AR.

Acta Trop. 1992 Feb;50(3):271-3. No abstract available.

PMID:
1348603
3.

Cymelarsan in the treatment of buffaloes naturally infected with Trypanosoma evansi in south China.

Lun ZR, Min ZP, Huang D, Liang JX, Yang XF, Huang YT.

Acta Trop. 1991 Aug;49(3):233-6.

PMID:
1685304
5.
6.

Effect of stage of infection with Trypanosoma evansi on Cymelarsan therapy.

Biswas RK, Hunter AG.

Trop Anim Health Prod. 1993 Nov;25(4):223-4. No abstract available.

PMID:
8109055
7.
8.

An outbreak of abortions and high neonatal mortality associated with Trypanosoma evansi infection in dromedary camels in the Canary Islands.

Gutierrez C, Corbera JA, Juste MC, Doreste F, Morales I.

Vet Parasitol. 2005 Jun 10;130(1-2):163-8. Epub 2005 Apr 7.

PMID:
15893083
9.

Use of cymelarsan in goats chronically infected with Trypanosoma evansi.

Gutierrez C, Corbera JA, Bayou K, van Gool F.

Ann N Y Acad Sci. 2008 Dec;1149:331-3. doi: 10.1196/annals.1428.095.

PMID:
19120242
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk